Zealand Pharma's total assets for Q2 2025 were kr17.18B, an increase of 88.33% from the previous quarter. ZLDPF total liabilities were kr1.57B for the fiscal quarter, a 93.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.